Walter Scherrer

Title: Walter Scherrer: Innovator in Pharmaceutical Formulations

Introduction

Walter Scherrer is a notable inventor based in Rheinfelden, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystal modifications and dosage forms. With a total of 5 patents to his name, Scherrer's work has had a meaningful impact on drug formulation and delivery.

Latest Patents

One of Scherrer's latest patents involves the crystal modification A of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide. This invention relates to dosage forms and formulations that utilize this novel crystal modification. Crystal modification A is characterized by specific interplanar spacings, determined through X-ray powder patterns. The dosage forms can be administered orally or parenterally, available in both solid and liquid forms, with a dosage range of 20 mg to less than 500 mg. Solid dosage forms include tablets or capsules, which also contain a pharmaceutically acceptable carrier and film-coat. Additionally, Scherrer has worked on novel modifications B and C of the same compound, focusing on their use and pharmaceutical preparations.

Career Highlights

Throughout his career, Walter Scherrer has been associated with prominent companies in the pharmaceutical industry, including Novartis AG and Ciba-Geigy AG. His work in these organizations has allowed him to contribute to significant advancements in drug formulation and delivery systems.

Collaborations

Scherrer has collaborated with notable colleagues such as Robert Portmann and Urs Christoph Hofmeier. These partnerships have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

Walter Scherrer is a distinguished inventor whose work in pharmaceutical formulations has led to innovative solutions in drug delivery. His contributions continue to influence the industry and improve patient outcomes.